Clinical Trial Update: Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age [Phase 2]

View source ↗

Summary

Phase 2 safety and pharmacokinetics study of Patanase (olopatadine nasal spray) in children aged 2 to less than 6 with allergic rhinitis; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Patanase (olopatadine)

Snippet

Sponsor: Alcon Research | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2010-02-04